Tiedemann Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,617
Closed -$274K – 248
2022
Q1
$274K Buy
3,617
+236
+7% +$18.7K 0.01% 238
2021
Q4
$288K Buy
3,381
+6
+0.2% +$469 0.01% 239
2021
Q3
$255K Sell
3,375
-843
-20% -$66.9K 0.01% 255
2021
Q2
$344K Buy
4,218
+1,183
+39% +$96.7K 0.01% 274
2021
Q1
$239K Sell
3,035
-706
-19% -$55.3K 0.01% 294
2020
Q4
$320K Buy
3,741
+879
+31% +$72.7K 0.02% 246
2020
Q3
$220K Buy
+2,862
New +$218K 0.01% 295
2019
Q2
– Sell
-20,477
Closed -$1.41M – 322
2019
Q1
$1.41M Sell
20,477
-1,838
-8% -$119K 0.07% 174
2018
Q4
$1.33M Buy
22,315
+14,149
+173% +$885K 0.07% 173
2018
Q3
$547K Sell
8,166
-1,067
-12% -$71.1K 0.03% 222
2018
Q2
$599K Buy
9,233
+1,043
+13% +$68.2K 0.04% 214
2018
Q1
$586K Buy
8,190
+4,998
+157% +$360K 0.04% 190
2017
Q4
$241K Buy
3,192
+2
+0.1% +$146 0.02% 201
2017
Q3
$233K Sell
3,190
-8,082
-72% -$582K 0.02% 311
2017
Q2
$836K Buy
11,272
+2,742
+32% +$204K 0.06% 237
2017
Q1
$624K Buy
8,530
+1,588
+23% +$111K 0.05% 243
2016
Q4
$454K Buy
6,942
+500
+8% +$34.3K 0.05% 225
2016
Q3
$461K Buy
+6,442
New +$476K 0.1% 98

Other funds holding CL

Tiedemann Advisors's CL Position: Q2 2022 in Review

Tiedemann Advisors sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 3,617 shares — an estimated $274K sold.

Tiedemann Advisors first reported a position in CL in Q3 2016 and held it in 18 quarters. The position peaked at $1.41M in Q1 2019. 1,669 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Tiedemann Advisors reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • Tiedemann Advisors sold 3,617 Colgate-Palmolive shares in Q2 2022, an estimated $274K.
  • Tiedemann Advisors first reported a position in Colgate-Palmolive in Q3 2016 and held it in 18 quarters.
  • Tiedemann Advisors's Colgate-Palmolive position peaked at $1.41M in Q1 2019.
  • 1,669 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Tiedemann Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.